What is Syntis Bio worth?
$67.0Mlast known valuation
Syntis Bio last raised $25.0M in its Early Stage VC (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Syntis Bio
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Early Stage VC | $25.0M | ▮ | ▮ |
| Dec 2024 | Early Stage VC | $6.3M | ▮ | ▮ |
| Aug 2022 | Early Stage VC | $15.4M | ▮ | ▮ |
How Syntis Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Syntis Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Syntis Bio worth?
- Syntis Bio's last known valuation is $67.0M.
- How much has Syntis Bio raised?
- Syntis Bio has raised $48.4M in total funding across 3 recorded rounds.
- When did Syntis Bio last raise?
- Syntis Bio last raised in Jun 2025 (Early Stage VC), raising $25.0M.